Ophthalmology thought-leaders set sights on ARVO’s annual meeting

March 14, 2019

Group offering ARVOLearn educational platform; AI focus of upcoming online session

More than 11,000 global thought-leaders are expected to descend upon Vancouver, BC, for the Association for Research in Vision and Ophthalmology’s (ARVO) 2019 annual meeting, April 28 to May 2.

This marks the first time the annual meeting will be held outside of the United States, and for the first time, ARVO received more abstract submissions from non-U.S. scientists than their U.S.-based counterparts.

Imaging in the eye

Being held in the Western Canadian city on April 26–27, the annual ARVO Imaging Conference is bringing together members of the basic science, clinical, engineering, and industrial communities who all share a common interest in new innovations, techniques, and methods for imaging in the eye and their applications to clinical ophthalmology, fundamental vision research, and biomedicine.

There will be some new additions to the agenda this year, including a Friday night speaker and panel discussion, featuring Philip J. Rosenfeld, MD, PhD, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine.

Dr. Rosenfeld will discuss OCT in the diagnosis and management of age-related macular degeneration. He has been a pioneer in the use of drugs to prevent blindness in neovascular (wet) age-related macular degeneration.

The session, which also includes a networking reception, will be held from 6:30 p.m. to 9 p.m. April 26.

Learn skills with Arvo
Education also is a priority for ARVO, which, in 2018, debuted its new online learning platform, ARVOLearn.

The platform uses the latest advances in online learning technology, allowing users to view session presentations from recent ARVO meetings, an on-demand course or a series of mini-courses available at their convenience.

ARVO Online Education also will offer a new event later this spring titled “Artificial Intelligence in Ocular Medicine: Seeing into the Future.”

The session will highlight the artificial intelligence (AI) technology that has been approved for clinical use or is currently in the development pipeline and how to integrate these potential technologies into a research or clinical practice.

The AI session also will feature panel discussions that will be live or recorded as well as a technology showcase with video presentations, a series of recorded presentations and discussion forums. Registration for the AI event opened earlier this month.

Myopia special issue

The journal Investigative Ophthalmology and Visual Science (IOVS) has released a special issue on myopia. This special issue has been produced in collaboration with the Australia-based International Myopia Institute.

The special issue was organized by Professors Earl Smith and James Wolffsohn and facilitated by Dr. Monica Jong, executive director of the institute.

The myopia special issue includes a series of white papers summarizing the current knowledge in the field, showing trends for future developments, and facilitating further research, by bridging gaps and connecting people who so far had not intensively exchanged information and ideas. ■

Disclosures:

JULENE JOYE: jjoy@arvo.org
Joy is assistant director, communications and digital strategy with the Association for Research in Vision and Ophthalmology.

References:

ARVO education, online offerings

To learn more about the ARVOLearn online learning platform, visit www.arvo.org/education.online-education/.

You also can learn more about “Artificial Intelligence in Ocular Medicine: Seeing into the Future” at www.arvo.org/education.ai-online-event/. 

To view the Investigative Ophthalmology & Visual Science special issue on myopia, visit https://iovs.arvojournals.org/issues.aspx?issueid=937872&journalid=177.

download issueDownload Issue : Ophthalmology Times, March 15 2019